Author Guidelines


1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


New submissions should be made via the Research Exchange submission portal Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

International Journal of Paediatric Dentistry will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

For help with submissions, please contact: [email protected]  


International Journal of Paediatric Dentistry publishes papers on all aspects of paediatric dentistry including: growth and development, behaviour management, diagnosis, prevention, restorative treatment and issue relating to medically compromised children or those with disabilities. This peer-reviewed journal features scientific articles, reviews, case reports, short communications and abstracts of current paediatric dental research. Analytical studies with a scientific novelty value are preferred to descriptive studies. Case reports illustrating unusual conditions and clinically relevant observations are acceptable but must be of sufficiently high quality to be considered for publication; particularly the illustrative material must be of the highest quality.


i. Original Articles

Divided into: Abstract, Introduction, Material and methods, Results, Discussion, Bullet points, Acknowledgements, References, Figure legends, Tables and Figures arranged in this order. 3500 word limit (Introduction to Discussion), with an exception of qualitative papers which allow a 5000 word limit (Introduction to Discussion).

  • Abstract should be structured using the following subheadings: Background, Aim, Design, Results and Conclusion and should be less than 200 words.
  • Introduction should be brief and end with a statement of the aim of the study or hypotheses tested. Describe and cite only the most relevant earlier studies. Avoid presentation of an extensive review of the field.
  • Material and methods should be clearly described and provide enough detail so that the observations can be critically evaluated and, if necessary repeated. Use section subheadings in a logical order to title each category or method. Use this order also in the results section. Authors should have considered the ethical aspects of their research and should ensure that the project was approved by an appropriate ethical committee, which should be stated. Type of statistical analysis must be described clearly and carefully.
  • Results should clearly and concisely report the findings, and division using subheadings is encouraged. Double documentation of data in text, tables or figures is not acceptable. Tables and figures should not include data that can be given in the text in one or two sentences.
  • Discussion section presents the interpretation of the findings. This is the only proper section for subjective comments and reference to previous literature. Avoid repetition of results, do not use subheadings or reference to tables in the results section.
  • Bullet Points: Authors will need to provide no more than 3 ‘key points’ that summarise the key messages of their paper to be published with their article. The key points should be written with a practitioner audience in mind under the heading:
    *Why this paper is important to paediatric dentists.

References: Maximum 30.

ii. Review Articles

May be invited by the Editor.

iii. Systematic reviews

We consider publishing systematic reviews if the manuscript has comprehensive and unbiased sampling of literature and covering topics related to Paediatric Dentistry.

References: Maximum 30.

Articles for the International Journal of Paediatric Dentistry should include: a) description of search strategy of relevant literature (search terms and databases), b) inclusion criteria (language, type of studies i.e. randomized controlled trial or other, duration of studies and chosen endpoints, c) evaluation of papers and level of evidence. For examples see:

Twetman S, Axelsson S, Dahlgren H et al. Caries-preventive effect of fluoride toothpaste: a systematic review. Acta Odontologica Scandivica 2003; 61: 347-355.

Paulsson L, Bondemark L, Söderfeldt B. A systematic review of the consequences of premature birth on palatal morphology, dental occlusion, tooth-crown dimensions, and tooth maturity and eruption. Angle Orthodontist 2004; 74: 269-279.

iv. Short Communications

Brief scientific articles or short case reports may be submitted, which should be no longer than three pages of double-spaced text and include a maximum of three illustrations. They should contain important, new, definitive information of sufficient significance to warrant publication. They should not be divided into different parts and summaries are not required.

References: Maximum 30.

v. Brief Clinical Reports/Case Reports

Short papers not exceeding 800 words, including a maximum of three illustrations and five references may be accepted for publication if they serve to promote communication between clinicians and researchers. If the paper describes a genetic disorder, the OMIM unique six-digit number should be provided for online cross reference (Online Mendelian Inheritance in Man).

A paper submitted as a Brief Clinical/Case Report should include the following:

  • a short Introduction (avoid lengthy reviews of literature);
  • the Case report itself (a brief description of the patient/s, presenting condition, any special investigations and outcomes);
  • a Discussion which should highlight specific aspects of the case(s), explain/interpret the main findings and provide a scientific appraisal of any previously reported work in the field.
  • Bullet Points: Authors will need to provide no more than 3 ‘key points’ that summarise the key messages of their paper to be published with their article. The key points should be written with a practitioner audience in mind under the heading:
    *Why this paper is important to paediatric dentists.

vi. Letters to the Editor

Letters should be no more than 1,500 words, with no more than 10 references. There should be no abstract, tables or figures.


Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, and results. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
      • data availability statement
      • funding statement
      • conflict of interest disclosure
      • ethics approval statement
      • patient consent statement
      • permission to reproduce material from other sources

If you are invited to revise your manuscript after peer review, the journal will also request the revised manuscript to be formatted according to journal requirements as described below. 

Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures.

Title page

The title page should contain:
i. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. A short running title of less than 50 characters;
iii. The full names of the authors and a statement of author contributions, e.g.
Author contributions: A.S. and K.J. conceived the ideas; K.J. and R.L.M. collected the data; R.L.M. and P.A.K. analysed the data; and A.S. and K.J. led the writing;
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
vi. Acknowledgments;
vii. Word count (excluding tables)


Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.


Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement. Conflict of Interest Forms, if submitted, need to submitted with the file designation “Supplementary File not for Review or Publication”.

Main Text File

As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors.

The main text file should be presented in the following order:

i. Title, abstract and key words;
ii. Main text;
iii. References;
iv. Tables (each table complete with title and footnotes);
v. A clinical trial registration number should be provided (when relevant)
vi. Figure legends;
vii. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Abstracts and keywords are required for some manuscript types. For details on manuscript types that require abstracts, please refer to the ‘Manuscript Types and Criteria’ section.

Main Text

  • As papers are double-blind peer reviewed, the main text file should not include any information that might identify the authors.
  • The journal uses British spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.


All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Internet document
3. American Cancer Society. Cancer Facts & Figures 2003. Accessed March 3, 2003


Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

In the text, please reference figures as for instance 'Figure 1', 'Figure 2' to match the tag name you choose for the individual figure files uploaded.

Colour Figures. Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

Data Citation

Please review Wiley’s data citation policy here.

Additional Files


Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

Submission of Revised Manuscripts

Revised manuscripts must be uploaded within 2 months of authors being notified of conditional acceptance pending satisfactory revision. Locate your manuscript under 'Manuscripts with Decisions' and click on 'Submit a Revision' to submit your revised manuscript. Please remember to delete any old files uploaded when you upload your revised manuscript. Revisions should not include tracked changes. All revisions must be accompanied by a cover letter to the editor.

Authors should supply their response to reviewers in the field provided for this at the beginning of their submission. The replies should include a) detail on a point-by-point basis the author's response to each of the referee's comments, and b) a revised manuscript highlighting exactly what has been changed in the manuscript after revision.

Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.

To Obtain Research Resource Identifiers (RRIDs)

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text. 

If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Example Citations

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (, RRID:nif-0000-00280)"

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        

Guidelines for Cover Submissions: If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are double-anonymised peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. 

Wiley's policy on the confidentiality of the review process is available here.

Appeals and Complaints

Authors may appeal an editorial decision if they feel that the decision to reject was based on either a significant misunderstanding of a core aspect of the manuscript, a failure to understand how the manuscript advances the literature or concerns regarding the manuscript-handling process. Differences in opinion regarding the novelty or significance of the reported findings are not considered as grounds for appeal. To raise an appeal, please contact the journal by email, quoting your manuscript ID number and explaining your rationale for the appeal. The editor’s decision following an appeal consideration is final.

To raise a complaint regarding editorial staff, policy or process please contact the journal in the first instance. If you believe further support outside the journal’s management is necessary, please refer to Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. When detailed descriptions, photographs, or videos of faces or identifiable body parts are used that may allow identification, authors should obtain the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. Where photographs are used they need to be cropped sufficiently to prevent human subjects being recognized; black eye bars should not be used as they do not sufficiently protect an individual’s identity).

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

Clinical trials should be reported using the CONSORT guidelines available at A clinical trial registration number should be provided in the title page. A CONSORT checklist should also be included in the submission material under “Supplementary Files for Review”.

If your study is a randomized clinical trial, you will need to fill in all sections of the CONSORT Checklist. If your study is not a randomized trial, not all sections of the checklist might apply to your manuscript, in which case you simply fill in N/A.

All prospective clinical trials which have a commencement date after the 31st January 2017 must be registered with a public trials registry:,, The clinical trial registration number and name of the trial register will then be published with the paper.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. The guidelines listed below should be followed where appropriate and where applicable, checklists, and flow diagrams uploaded with your submission; these may be published alongside the final version of your paper.

Observational studies : STROBE checklists for cohort, case-control, and cross-sectional studies, either individual or combined
Systematic reviews : PRISMA
• Meta-analyses of observational studies: MOOSE
Case reports : CARE
• In vitro studies: CRIS
Qualitative research : COREQ
Diagnostic / prognostic studies : STARD
Quality improvement studies : SQUIRE
Economic evaluations : CHEERS
Animal pre-clinical studies : ARRIVE
Study protocols : SPIRIT
Clinical practice guidelines : AGREE

The Equator Network (Enhancing the Quality and Transparency Of Health Research) provides a comprehensive list of reporting guidelines.

We also encourage authors to refer to and follow guidelines from:

Future of Research Communications and e-Scholarship (FORCE11)
National Research Council's Institute for Laboratory Animal Research guidelines
The Gold Standard Publication Checklist from Hooijmans and colleagues
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website
FAIRsharing website

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ;
  • Proteins and nucleic acids: Protein Data Bank (
  • NMR spectroscopy data: BioMagResBank (

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

It is the responsibility of the corresponding author to have all authors of a manuscript fill out a conflict of interest disclosure form, and to upload all forms together with the manuscript on submission. Please find the form below:

Conflict of Interest Disclosure Form

The form above does not display correctly in the browsers. If you see an error message starting with "Please wait...", we recommend that you download the file to your computer. Saving a local copy on your computer should allow the form to work properly.


Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature:


The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Data Sharing and Data Accessibility

Please review Wiley’s policy here. This journal encourages and peer review data sharing.

The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Sample statements are available here. If published, statements will be placed in the heading of your manuscript.

Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: If you choose to publish using Open Access you will be charged a fee (APC).For more information on this journal’s APCs, please see the Open Access page.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

Reproduction of Copyright Material: If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at


Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, most common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.  

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


Access and sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article

To find out how to best promote an article, click here.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request. 


For queries about submissions, please contact [email protected]

Author Guidelines Updated 08 February 2021